Best available Treatment (BAT) Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Chronic Graft Versus Host Disease
Incyte Corporation60 enrolled41 locationsNCT07124078
Recruiting
Phase 2
Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT
Mats Remberger50 enrolled6 locationsNCT04118556